Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-004978-25Phase 3Active
Phase 3, open-label, single-arm trial of annovera in contraception, sponsored by International Committee for Contraception Research. Primary endpoint: Pearl Index per 100 woman-years for women ≤ 35 years. Started Jul 2006; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-004978-25.